52-week Open Label Safety-Tolerability Study
Public ClinicalTrials.gov record NCT07369154. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 52 Week, Open Label Safety and Tolerability Study of LB-102 in Adult Patients With Schizophrenia
Study identification
- NCT ID
- NCT07369154
- Recruitment status
- Not yet recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- LB Pharmaceuticals Inc.
- Industry
- Enrollment
- 900 participants
Conditions and interventions
Conditions
Interventions
- LB-102 Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 31, 2026
- Primary completion
- Nov 30, 2028
- Completion
- Mar 31, 2029
- Last update posted
- May 14, 2026
2026 – 2029
United States locations
- U.S. sites
- 23
- U.S. states
- 13
- U.S. cities
- 21
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Chandler Clinical Trials | Chandler | Arizona | 85224 | — |
| Pillar Clinical Research | Bentonville | Arkansas | 72712 | — |
| Pillar Clinical Research | Little Rock | Arkansas | 72204 | — |
| Woodland International Research Group | Little Rock | Arkansas | 72211 | — |
| Advanced Research Center | Anaheim | California | 92805 | — |
| Synapse Clinical Trials | Cerritos | California | 90703 | — |
| ProScience Research Group | Culver City | California | 90230 | — |
| CenExel | Culver City | California | 92845 | — |
| Synergy San Diego | San Diego | California | 92064 | — |
| CenExel | Hollywood | Florida | 33024 | — |
| Segal Trials | Miami Lakes | Florida | 33063 | — |
| Health Synergy Clinical Research | West Palm Beach | Florida | 33407 | — |
| CenExel | Atlanta | Georgia | 30331 | — |
| Accelerated Clinical Trial | Snellville | Georgia | 30078 | — |
| Pillar Clinical Research | Chicago | Illinois | 60641 | — |
| CenExel Gaithersburg | Gaithersburg | Maryland | 20877 | — |
| Arch Clinical Trials | St Louis | Missouri | 63141 | — |
| Redbird Research | Las Vegas | Nevada | 89119 | — |
| Neuro-Behavioral Clinical Research | New York | New York | 11516 | — |
| Neuro-Behavioral Clinical Research | Canton | Ohio | 44720 | — |
| Adams Clinical | Philadelphia | Pennsylvania | 19104 | — |
| Adams Clinical | DeSoto | Texas | 75115 | — |
| Pillar Clinical Research | Richardson | Texas | 75080 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07369154, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 14, 2026 · Synced May 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07369154 live on ClinicalTrials.gov.